DoseMarks
FDA-approved (brand)Growth hormone–releasing hormone analog

Tesamorelin Dosage Calculator

Tesamorelin preparation depends on the exact formulation. Use its labeled concentration after preparation and your prescribed dose; do not infer a branded product’s concentration from an example vial.

Example vial inputs
2 mg · 5 mg · 10 mg

FDA-approved as EGRIFTA SV® and EGRIFTA WR™ for excess abdominal fat in adults with HIV-associated lipodystrophy. These formulations are not interchangeable.

Step 1

Your vial & dose

U-100 syringes

What’s in your vial?

Vial values are examples. Replace them with your product or pharmacy label values.

Copy the concentration (mg/mL) from your pharmacy label. Don’t add water to a vial that is already liquid.

mg/mL
mL

Step 2

mg

Type the dose exactly as written on your prescription or label. We don’t suggest doses.

Step 3

Syringe size

Smaller barrels have finer marks, which makes small doses easier to read.

Live syringe preview · 100-unit

01020304050607080901000u

Draw to

—

Enter the dose on your prescription to see how many units to draw.

Concentration
5 mg/mL
Each unit contains
50 mcg

Quick reference

Units → dose at your concentration

5 mg/mL · 50 mcg per unit

Arithmetic examples only. These amounts are not suggested doses.

2 units

100 mcg

0.02 mL

5 units

250 mcg

0.05 mL

10 units

500 mcg

0.1 mL

15 units

750 mcg

0.15 mL

20 units

1 mg

0.2 mL

25 units

1.25 mg

0.25 mL

30 units

1.5 mg

0.3 mL

40 units

2 mg

0.4 mL

50 units

2.5 mg

0.5 mL

60 units

3 mg

0.6 mL

75 units

3.75 mg

0.75 mL

100 units

5 mg

1 mL

Dosing schedule

Is there a standard Tesamorelin dose?

Follow the dosing on your prescription label. This page converts that dose into syringe units.

Before reconstitution

Five checks for a powder vial

For powder (freeze-dried) vials only. If your vial arrived as a liquid, it is already mixed — never add water to it; use the concentration on the label. EGRIFTA SV and WR require their own supplied diluents and preparation instructions. For WR, use the labeled 8 mg/mL concentration after preparation; dividing 11.6 mg by the 1.3 mL added does not give its labeled concentration.

  1. 01

    Check the product

    Confirm that you have a powder intended for preparation and the instructions for that exact product. Ask your pharmacist if anything is unclear.

  2. 02

    Confirm the diluent

    Use only the diluent and volume specified in those instructions. The calculator cannot determine whether a diluent or mixing volume is suitable.

  3. 03

    Follow the instructions

    Follow the product’s preparation method and the technique your pharmacist taught you. These checks are not a substitute for its Instructions for Use.

  4. 04

    Verify concentration

    Use the labeled concentration after preparation, or the total drug amount and final solution volume. The final volume may differ from the amount of diluent added.

  5. 05

    Check storage & discard

    Follow the product’s storage conditions and discard time. Some preparations require immediate use. Do not infer a storage period from the calculator.

Storing your vial

  • EGRIFTA SV (2 mg vial): keep the unmixed kit at 20–25 °C (68–77 °F), with medication protected from light. After preparation, use immediately and discard unused solution and diluent. Do not store, refrigerate or freeze the mixed solution.
  • EGRIFTA WR (11.6 mg vial): keep at 20–25 °C (68–77 °F), protected from light. After preparation, keep the vial at that room temperature in its medication box and discard after 7 days. Do not refrigerate or freeze the mixed solution. Discard the supplied bacteriostatic water 28 days after first use.
  • These instructions are specific to SV and WR. For another formulation, ask the pharmacist for its own preparation, storage and discard instructions.

Please read before injecting

Always confirm your dose, concentration and syringe markings with your prescriber or pharmacist. Small calculation errors can have serious consequences. This tool does math — it doesn’t tell you what dose to take.

Sources

References

Last updated October 2026.

Related

Other calculators

Not FDA-approved

CJC-1295 / Ipamorelin

Growth-hormone secretagogue blend

Example vial inputs: 5 mg, 10 mg

Open calculator

Investigational

Retatrutide

GIP / GLP-1 / glucagon receptor agonist

Example vial inputs: 5 mg, 10 mg, 20 mg

Open calculator

FDA-approved (brand)

Tirzepatide

GIP / GLP-1 receptor agonist

Example vial inputs: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg

Open calculator